Condition
Lung Cancer|Mesothelioma
Estimated Enrollment: 5
Age Group: 18 Years and older (Adult, Senior)
Gender: All
Study Type: Interventional
Study Design Allocation: Intervention Model: Single Group Assignment|Masking: Open Label|Primary Purpose: Treatment
Study ID Numbers: 08-0106
Study First Received: September 4, 2008
Last Updated: June 30, 2015
Estimated Primary Completion Date: July 2009
Primary Outcome Measures:
Efficacy of the Cryogen on a Tumor Evaluated by Histopathological Data and Visual Inspection Along With Visual Confirmation of Absence of Scarring and Stricturing of the Airway. The Primary Safety Endpoint is the Reporting of All Adverse Events.|Consists of a Measure of Treatment Efficacy and Improvement in Luminal Patency Assessed by Visual Inspection.
Sponsors and Collaborators:
CSA Medical, Inc.
Website Link: https://ClinicalTrials.gov/show/NCT00748085
